Mesenchymal stem cells: current clinical progress in ARDS and COVID-19
Abstract Acute respiratory distress syndrome (ARDS) develops rapidly and has a high mortality rate. Survivors usually have low quality of life. Current clinical management strategies are respiratory support and restricted fluid input, and there is no suggested pharmacological treatment. Mesenchymal...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2020-07-01
|
| coleção: | Stem Cell Research & Therapy |
| Assuntos: | |
| Acesso em linha: | http://link.springer.com/article/10.1186/s13287-020-01804-6 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|